Tebipenem pivoxil as an alternative to ceftriaxone for clinically non-responding children with shigellosis: a randomised non-inferiority trial protocol
Authors
Subhasish Das (ORCID: https://orcid.org/0000-0002-7852-6569)
Dilruba Ahmed (ORCID: https://orcid.org/0000-0001-8961-2406)
Tebipenem pivoxil as an alternative to ceftriaxone for clinically non-responding children with shigellosis: a randomised non-inferiority trial protocol
Subhasish Das, Dilruba Ahmed, Firdausi Qadri, Elena Fernández Álvaro et al.
Journal
BMJ Open
Topics
Antibiotic Resistance in Bacteria
article
Tebipenem pivoxil as an alternative to ceftriaxone for clinically non-responding children with shigellosis: a randomised non-inferiority trial protocol
Subhasish Das, Dilruba Ahmed, Firdausi Qadri, Elena Fernández Álvaro, Samuel L.M. Arnold, Patricia B. Pavlinac, Juliet Addo, Syed Khairul Bashar, Sharika Nuzhat, Farhana Khanam, Rachel A. Gibson, Md Ridwan Islam, Tahmeed Ahmed, Mohammod Jobayer Chisti, Amy Newlands
article en
Abstract
No abstract available for this paper.
Publication Tag
BMJ OpenVol. 15(2)
Institutions
GlaxoSmithKline (United Kingdom) (GB), University of Washington (US), International Centre for Diarrhoeal Disease Research (BD), Age UK (GB)